13-48411623-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001162498.3(LPAR6):​c.801A>C​(p.Ala267Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00239 in 1,612,216 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 2 hom. )

Consequence

LPAR6
NM_001162498.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.83

Publications

2 publications found
Variant links:
Genes affected
LPAR6 (HGNC:15520): (lysophosphatidic acid receptor 6) The protein encoded by this gene belongs to the family of G-protein coupled receptors, that are preferentially activated by adenosine and uridine nucleotides. This gene aligns with an internal intron of the retinoblastoma susceptibility gene in the reverse orientation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2009]
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1 Gene-Disease associations (from GenCC):
  • hereditary retinoblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • retinoblastoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • melanoma
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-48411623-T-G is Benign according to our data. Variant chr13-48411623-T-G is described in ClinVar as Likely_benign. ClinVar VariationId is 780057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00141 (214/152294) while in subpopulation NFE AF = 0.00251 (171/68008). AF 95% confidence interval is 0.00221. There are 1 homozygotes in GnomAd4. There are 88 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001162498.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPAR6
NM_001162498.3
MANE Select
c.801A>Cp.Ala267Ala
synonymous
Exon 1 of 1NP_001155970.1P43657
RB1
NM_000321.3
MANE Select
c.1695+30180T>G
intron
N/ANP_000312.2P06400
LPAR6
NM_001162497.3
c.801A>Cp.Ala267Ala
synonymous
Exon 5 of 5NP_001155969.1P43657

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPAR6
ENST00000620633.5
TSL:5 MANE Select
c.801A>Cp.Ala267Ala
synonymous
Exon 1 of 1ENSP00000482660.1P43657
LPAR6
ENST00000378434.8
TSL:1
c.801A>Cp.Ala267Ala
synonymous
Exon 7 of 7ENSP00000367691.3P43657
RB1
ENST00000267163.6
TSL:1 MANE Select
c.1695+30180T>G
intron
N/AENSP00000267163.4P06400

Frequencies

GnomAD3 genomes
AF:
0.00140
AC:
213
AN:
152176
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00250
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00138
AC:
344
AN:
250116
AF XY:
0.00149
show subpopulations
Gnomad AFR exome
AF:
0.000558
Gnomad AMR exome
AF:
0.000493
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00238
Gnomad OTH exome
AF:
0.000984
GnomAD4 exome
AF:
0.00250
AC:
3647
AN:
1459922
Hom.:
2
Cov.:
31
AF XY:
0.00248
AC XY:
1799
AN XY:
726396
show subpopulations
African (AFR)
AF:
0.000509
AC:
17
AN:
33412
American (AMR)
AF:
0.000403
AC:
18
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
14
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39616
South Asian (SAS)
AF:
0.000986
AC:
85
AN:
86200
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53362
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5758
European-Non Finnish (NFE)
AF:
0.00305
AC:
3385
AN:
1110408
Other (OTH)
AF:
0.00179
AC:
108
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
170
340
510
680
850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00141
AC:
214
AN:
152294
Hom.:
1
Cov.:
32
AF XY:
0.00118
AC XY:
88
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41572
American (AMR)
AF:
0.000720
AC:
11
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00251
AC:
171
AN:
68008
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00168
Hom.:
0
Bravo
AF:
0.00136
EpiCase
AF:
0.00256
EpiControl
AF:
0.00202

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.5
DANN
Benign
0.75
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4151552; hg19: chr13-48985759; COSMIC: COSV57307467; COSMIC: COSV57307467; API